Abstract
Nanomaterials are invading our environment due to their increasing use in a very broad range of sectors making human exposure foreseeable during the life cycle of these materials. Inhalation is one of the most frequent routes of exposure in case of unintentional exposure and the small size of nanomaterials allows them to reach the deep lung. Understanding the fate and effects of nanomaterials is a great challenge for scientists as they exhibit a huge physico-chemical diversity that drives their biological reactivity. It is critical to determine the fate of nanomaterials at their route of entry in the organism as this will determine their local and/or systemic effects. In this review we will describe the epithelial barriers and the clearance processes of the respiratory tract. The mechanisms involved in the internalization of nanomaterials by respiratory cells and their ability to cross the epithelial barrier will be presented, highlighting methodologies and the role of the nanomaterial physico-chemical properties.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stone V, Miller MR, Clift MJ et al (2016) Nanomaterials vs ambient ultrafine particles: an opportunity to exchange toxicology knowledge. Environ Health Perspect. https://doi.org/10.1289/EHP424
MPPD, Multiple-Path Particle Dosimetry Model (n.d) (MPPD v 3.04) https://www.ara.com/products/multiple-path-particle-dosimetry-model-mppd-v-304
Doherty GJ, McMahon HT (2009) Mechanisms of endocytosis. Annu Rev Biochem 78:857–902
Roiter Y, Ornatska M, Rammohan AR et al (2009) Interaction of lipid membrane with nanostructured surfaces. Langmuir 25(11):6287–6299
Vranic S, Garcia-Verdugo I, Darnis C et al (2013) Internalization of SiO2 nanoparticles by alveolar macrophages and lung epithelial cells and its modulation by the lung surfactant substitute Curosurf. Environ Sci Pollut Res Int 20(5):2761–2770
Vranic S, Boggetto N, Contremoulins V et al (2013) Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry. Part Fibre Toxicol 10:2
Astolfo A, Arfelli F, Schültke E et al (2013) A detailed study of gold-nanoparticle loaded cells using X-ray based techniques for cell-tracking applications with single-cell sensitivity. Nanoscale 5(8):3337–3345
Drescher D, Kneipp J (2012) Nanomaterials in complex biological systems: insights from Raman spectroscopy. Chem Soc Rev 41(17):5780–5799
Vercauteren D, Vandenbroucke RE, Jones AT et al (2010) The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther 18(3):561–569
Ivanov AI (2008) Pharmacological inhibition of endocytic pathways: is it specific enough to be useful? Methods Mol Biol 440:15–33
Brandenberger C, Mühlfeld C, Ali Z et al (2010) Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small 6(15):1669–1678
Thorley AJ, Ruenraroengsak P, Potter TE et al (2014) Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium. ACS Nano 8(11):11778–11789
Bohmer N, Jordan A (2015) Caveolin-1 and CDC42 mediated endocytosis of silica-coated iron oxide nanoparticles in HeLa cells. Beilstein J Nanotechnol 6:167–176
Kasper J, Hermanns MI, Bantz C et al (2013) Flotillin-involved uptake of silica nanoparticles and responses of an alveolar-capillary barrier in vitro. Eur J Pharm Biopharm 84(2):275–287
Rothen-Rutishauser BM, Schürch S, Haenni B et al (2006) Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ Sci Technol 40(14):4353–4359
Zhao Y, Sun X, Zhang G et al (2011) Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 5(2):1366–1375
Hussain S, Thomassen LC, Ferecatu I et al (2010) Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells. Part Fibre Toxicol 7:10
Nabeshi H, Yoshikawa T, Arimori A et al (2011) Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Res Lett 6(1):93
Fröhlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 7:5577–5591
Kirch J, Guenther M, Doshi N et al (2012) Mucociliary clearance of micro- and nanoparticles is independent of size, shape and charge – an ex vivo and in silico approach. J Control Release 159(1):128–134
Florez L, Herrmann C, Cramer JM et al (2012) How shape influences uptake: interactions of anisotropic polymer nanoparticles and human mesenchymal stem cells. Small 8(14):2222–2230
Meng H, Yang S, Li Z et al (2011) Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano 5(6):4434–4447
Donaldson K, Murphy FA, Duffin R et al (2010) Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 7:5
Zhang B, Feng X, Yin H et al (2017) Anchored but not internalized: shape dependent endocytosis of nanodiamond. Sci Rep 7:46462
Mura S, Hillaireau H, Nicolas J et al (2011) Biodegradable nanoparticles meet the bronchial airway barrier: how surface properties affect their interaction with mucus and epithelial cells. Biomacromolecules 12(11):4136–4143
Ruge CA, Schaefer UF, Herrmann J et al (2012) The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One 7(7):e40775
McKenzie Z, Kendall M, Mackay RM et al (2015) Surfactant protein A (SP-A) inhibits agglomeration and macrophage uptake of toxic amine modified nanoparticles. Nanotoxicology 9(8):952–962
Shaw CA, Mortimer GM, Deng ZJ et al (2016) Protein corona formation in bronchoalveolar fluid enhances diesel exhaust nanoparticle uptake and pro-inflammatory responses in macrophages. Nanotoxicology 10(7):981–991
Vranic S, Gosens I, Jacobsen NR et al (2017) Impact of serum as a dispersion agent for in vitro and in vivo toxicological assessments of TiO2 nanoparticles. Arch Toxicol 91(1):353–363
Braakhuis HM, Park MV, Gosens I et al (2014) Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol 11:18
Churg A, Brauer M, del Carmen A-CM et al (2003) Chronic exposure to high levels of particulate air pollution and small airway remodeling. Environ Health Perspect 111(5):714–718
Setyawati MI, Tay CY, Chia SL et al (2013) TiO2 nanomaterials cause endothelial cells leakiness by disrupting the homophilic interaction of VE-cadherin. Nat Commun 4:1673
Geys J, Nemery B, Hoet PH (2007) Optimisation of culture conditions to develop an in vitro pulmonary permeability model. Toxicol In Vitro 21(7):1215–1219
George I, Vranic S, Boland S et al (2015) Development of an in vitro model of human bronchial epithelial barrier to study nanoparticle translocation. Toxicol In Vitro 29(1):51–58
Bachler G, Losert S, Umehara Y et al (2015) Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments. Part Fibre Toxicol 12:18
Kemp SJ, Thorley AJ, Gorelik J et al (2008) Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. Am J Respir Cell Mol Biol 39(5):591–597
Geys J, Coenegrachts L, Vercammen J et al (2006) In vitro study of the pulmonary translocation of nanoparticles: a preliminary study. Toxicol Lett 160(3):218–226
George I, Naudin G, Boland S et al (2015) Metallic oxide nanoparticle translocation across the human bronchial epithelial barrier. Nanoscale 7(10):4529–4544
Cohen JM, Derk R, Wang L et al (2014) Tracking translocation of industrially relevant engineered nanomaterials (ENMs) across alveolar epithelial monolayers in vitro. Nanotoxicology 1:216–225
Kreyling WG, Semmler-Behnke M, Takenaka S et al (2013) Differences in the biokinetics of inhaled nano- versus micrometer-sized particles. Acc Chem Res 46(3):714–722
Nemmar A, Hoet PH, Vanquickenborne B et al (2002) Passage of inhaled particles into the blood circulation in humans. Circulation 105(4):411–414
Mills NL, Amin N, Robinson SD et al (2006) Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med 173(4):426–431
Wiebert P, Sanchez-Crespo A, Falk R et al (2006) No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol 18(10):741–747
Nemmar A, Vanbilloen H, Hoylaerts MF et al (2001) Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. A J Respir Crit Care Med 164:1666–1668
Kreyling WG, Semmler-Behnke M, Seitz J et al (2009) Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol Suppl 1:55–60
Choi HS, Ashitate Y, Lee JH et al (2010) Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol 28(12):1300–1304
Elder A, Gelein R, Silva V et al (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 114(8):1172–1178
Abid A D, Anderson D S, Das G K et al (2013) Novel lanthanide-labeled metal oxide nanoparticles improve the measurement of in vivo clearance and translocation. Part Fibre Toxicol 0:1
Shinohara N, Osima Y, Kobayashi T et al (2015) Pulmonary clearance kinetics and extrapulmonary translocation of seven titanium dioxide nano- and submicron materials following intratracheal administration in rats. Nanotoxicology 9(8):1050–1058
Kreyling WG, Semmler M, Erbe F et al (2002) Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A 65(20):1513–1530
Semmler M, Seitz J, Erbe F et al (2004) Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 16(6–7):453–459
Lipka J, Semmler-Behnke M, Sperling RA et al (2010) Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31(25):6574–6581
Geiser M, Stoeger T, Casaulta M et al (2014) Biokinetics of nanoparticles and susceptibility to particulate exposure in a murine model of cystic fibrosis. Part Fibre Toxicol 11:19
Konduru NV, Jimenez RJ, Swami A et al (2015) Silica coating influences the corona and biokinetics of cerium oxide nanoparticles. Part Fibre Toxicol 12:31
Kreyling WG, Hirn S, Möller W et al (2014) Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size. ACS Nano 8(1):222–233
Sarlo K, Blackburn KL, Clark ED et al (2009) Tissue distribution of 20 nm, 100 nm and 1000nm fluorecent polystryrene latex nanospheres following acute systemic or acute and repeat aiway exposure in the rat. Toxicology (263):117–126
Kreyling WG (2016) Discovery of unique and ENM- specific pathophysiologic pathways: Comparison of the translocation of inhaled iridium nanoparticles from nasal epithelium versus alveolar epithelium towards the brain of rats. Toxicol Appl Pharmacol 299:41–46
Oberdorster G, Sharp Z, Atudorei V et al (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445
Garbuzenko OB, Winkler J, Tomassone MS et al (2014) Biodegradable Janus Nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs. Langmuir:12941–12949
Konduru N, Keller J, Ma-Hock L et al (2014) Biokinetics and effects of barium sulfate nanoparticles. Part Fibre Toxicol 11:55
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 The Author(s)
About this chapter
Cite this chapter
Puisney, C., Baeza-Squiban, A., Boland, S. (2018). Mechanisms of Uptake and Translocation of Nanomaterials in the Lung. In: Saquib, Q., Faisal, M., Al-Khedhairy, A., Alatar, A. (eds) Cellular and Molecular Toxicology of Nanoparticles. Advances in Experimental Medicine and Biology, vol 1048. Springer, Cham. https://doi.org/10.1007/978-3-319-72041-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-72041-8_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72040-1
Online ISBN: 978-3-319-72041-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)